CaĆeda, Ruben A.
HRN: 27-25-79 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/06/2025
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
06/06/2025
06/13/2025
IV
5mL
QID
T/C Oral Candidiasis
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes